World news, news around town, tech update 3
Ad
Sunday, 5 November 2017
Novartis seeks European approval of cell therapy Kymriah
ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment